Bristol-Myers Squibb Company (BMY)
NYSE: BMY · Real-Time Price · USD
48.94
-0.04 (-0.08%)
At close: Jul 24, 2025, 4:00 PM
49.13
+0.19 (0.39%)
After-hours: Jul 24, 2025, 7:58 PM EDT
BMY Employees
Bristol-Myers Squibb Company had 34,100 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
34,100
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$1,396,950
Profits / Employee
$158,915
Market Cap
99.60B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 34,100 | 0 | - |
Dec 31, 2023 | 34,100 | -200 | -0.58% |
Dec 31, 2022 | 34,300 | 2,100 | 6.52% |
Dec 31, 2021 | 32,200 | 1,950 | 6.45% |
Dec 31, 2020 | 30,250 | 250 | 0.83% |
Dec 31, 2019 | 30,000 | 6,700 | 28.76% |
Dec 31, 2018 | 23,300 | -400 | -1.69% |
Dec 31, 2017 | 23,700 | -1,300 | -5.20% |
Dec 31, 2016 | 25,000 | 0 | - |
Dec 31, 2015 | 25,000 | 0 | - |
Dec 31, 2014 | 25,000 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
BMY News
- 3 days ago - Bristol Myers Squibb's Supplemental New Drug Application (sNDA) for Sotyktu (deucravacitinib) for the Treatment of Adults with Active Psoriatic Arthritis Accepted for Review Across Four Regions Globally - Business Wire
- 6 days ago - July's 5 Dividend Growth Stocks With Yields Up To 7.96% - Seeking Alpha
- 6 days ago - Bristol Myers' drug fails to meet main goal of late-stage anemia trial - Reuters
- 6 days ago - Bristol Myers Squibb Announces Topline Results from Phase 3 INDEPENDENCE Trial for Reblozyl® (luspatercept-aamt) in Adult Patients with Myelofibrosis-Associated Anemia - Business Wire
- 7 days ago - Bristol Myers Squibb, Pfizer to sell blockbuster blood thinner Eliquis at 40% discount - CNBC
- 7 days ago - Bristol Myers, Pfizer to sell blood thinner Eliquis directly to patients - Reuters
- 7 days ago - Bristol Myers Squibb and Pfizer Announce Direct-to-Patient Eliquis® (apixaban) Option - Business Wire
- 7 days ago - Bristol-Myers Squibb and Pfizer plan to sell the widely used blood thinner Eliquis directly to patients at a discounted cash price - WSJ